13F-HR: CVS Health Corp's Q1 2024 13F Filing Reveals $211.8 Million in Holdings

CVS Health Corp's latest 13F filing discloses $211.8 million in managed securities as of March 31, 2024, with significant positions in SPDR S&P 500 ETF Trust and Vanguard Whitehall Fds.

Summary

• CVS Health Corp filed its Form 13F for the quarter ended March 31, 2024.
• The filing reports total holdings valued at $211,778,622.
• The report includes six holdings.
• Key holdings include SPDR S&P 500 ETF Trust ($150,587,145) and Vanguard Whitehall Fds ($30,493,352).
• The filing indicates sole voting authority for all shares reported.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, providing factual information about the company's holdings. The sentiment is neutral as it doesn't contain any explicit positive or negative statements.

Positives

• The filing provides transparency into CVS Health Corp's investment portfolio.
• The portfolio is diversified across multiple securities.

Industry Context

Form 13F filings are required for institutional investment managers with at least $100 million in assets under management, providing insights into their investment strategies and holdings.

Comparison to Industry Standards

• Comparing CVS Health Corp's holdings to those of other large institutional investors can reveal trends in investment preferences.
• Analyzing the allocation of assets across different sectors and asset classes can provide insights into CVS Health Corp's investment strategy relative to its peers.
• Comparing the performance of CVS Health Corp's holdings to relevant benchmarks, such as the S&P 500, can assess the effectiveness of its investment decisions.

Stakeholder Impact

• Shareholders can use this information to understand the investment strategy of CVS Health Corp.
• The filing provides transparency to the market regarding CVS Health Corp's investment decisions.

Key Dates